Householder Group Estate & Retirement Specialist’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$0 Sell
8
-16
-67% -$317 ﹤0.01% 580
2024
Q3
$0 Buy
+24
New +$548 ﹤0.01% 1157
2024
Q2
Sell
-24
Closed -$478 1190
2024
Q1
$478 Sell
24
-12
-33% -$232 ﹤0.01% 1159
2023
Q4
$0 Hold
36
﹤0.01% 1125
2023
Q3
$729 Buy
+36
New +$816 ﹤0.01% 1168
2023
Q1
$1K Sell
36
-10
-22% -$290 ﹤0.01% 1123
2022
Q4
$1K Buy
46
+10
+28% +$245 ﹤0.01% 327
2022
Q3
$0 Buy
+36
New +$941 ﹤0.01% 1084

Other funds holding AVNS

Householder Group Estate & Retirement Specialist's AVNS Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Avanos Medical (AVNS) stake by 67% in Q4 2024, selling an estimated $317 and leaving 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #580.

Householder Group Estate & Retirement Specialist first reported a position in AVNS in Q3 2022 and has held it in 8 quarters since. The position peaked at $1K in Q1 2023. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 8 shares of Avanos Medical worth $0 as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 16 Avanos Medical shares in Q4 2024, an estimated $317.
  • Avanos Medical made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #580 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Avanos Medical in Q3 2022 and has held it in 8 quarters since.
  • Householder Group Estate & Retirement Specialist's Avanos Medical position peaked at $1K in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.